News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

PIKAMAB Awarded Two Qualifying Therapeutic Discovery Project Grants


11/3/2010 11:46:14 AM

MENLO PARK, Calif.--(BUSINESS WIRE)--PIKAMAB, a biopharmaceutical company specializing in stratified medicine, announced today that it has been awarded two grants by the U.S. Government under the QTDP program to advance the development and commercialization of two theragnostic products: ADCC TherasightTM and Lupus TherasightTM. PIKAMAB applied for two grants, both of which qualified and received the maximum grant amounts totaling approximately $488,959.

Read at BioSpace.com

comments powered by Disqus
PIKAMAB
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES